The present study is a large, well-characterized multicenter cohort, with a robust sample size and detailed clinical and laboratory profiling, to simultaneously assess serum levels of both IFN-α and IFN-γ in patients with SLE. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.